The presence of viral replication in these cancers presents a potential therapeutic target, as reducing viral replication will ultimately reduce the levels of E6 and E7 proteins potentially increasing the expression of their tumor suppressor targets p53 and pRb, respectively. The gene discussed is RB1; the disease is cancer.